Uterine Arterial Embolization for the Treatment of Leiomyomas Accompanying with Adenomyosis.
- Author:
Jin Beum JANG
;
Sang Wook BAI
;
Jae Hak LIM
;
Do Yeon LEE
;
Jung Yeon KIM
;
Kyung Ah JEONG
;
Sei Kwang KIM
;
Ki Hyun PARK
- Publication Type:Original Article
- Keywords:
Uterine artery embolization;
Leiomyoma;
Adenomyosis;
Occluding agent;
Resistance index
- MeSH:
Adenomyosis*;
Female;
Fertility;
Follow-Up Studies;
Gelatin Sponge, Absorbable;
Humans;
Korea;
Leiomyoma*;
Menorrhagia;
Myoma;
Polyvinyl Alcohol;
Retrospective Studies;
Ultrasonography;
Uterine Artery Embolization
- From:Korean Journal of Fertility and Sterility
2001;28(3):215-224
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: The purpose of this study was to make a guideline of uterine artery embolization for the treatment of uterine leiomyomas accompanying with adenomyosis in Korea. MATERIALS AND METHODS: We performed the retrospective study for 37 women who had uterine leiomyomas accompanying with adenomyosis. Bilateral uterine artery embolization was performed in 37 patients (age range 25-65) during 17 months with pain, hypermenorrhea, urinary frequency etc due to leiomyomas. Ultrasound imaging was performed before the procedure and at mean 6.9 months after the procedure. RESULTS: All procedures were technically successful. Mean clinical follow-up was 12.8 months. Minor complication occurred in 82% patients after the procedure. After imaging follow-up (mean, 6.9 months postprocedure), median uterine volume decreased 34.4%, and dominant myoma volume decreased 86%. There was no statistical difference in uterine volume reduction and dominant myoma size reduction whether occluding agents was polyvinyl alcohol, polyvinyl alcohol plus gelfoam, and gelfoam, and whether ultrasound measured Resistance Index value before the procedure was low or high. CONCLUSION: Primary candidates for uterine artery embolization include those with symptomatic uterine leiomyomas who no longer desire fertility but wish to avoid surgery or are poor surgical risks. To our study, uterine volume reduction and dominant myoma size reduction in patients who had adenomyosis were similar to previous other studies in patients who had not adenomyosis. Therefore adenomyosis should not be considered as a contraindication for uterine artery embolization. Because there is little data about subsequent reproductive potential after this procedure, it should not be routinely advocated for infertile women. Further investigation is warranted for occluding agents and Resistance Index.
